There have been cases where customers have received insulin instead of their expected weight-loss drugs from these types of shady sellers
Wegovy and Ozempic contain the same active ingredient, semaglutide, and are injected weekly
Patients should never discontinue GLP-1 medication abruptly without medical guidance
Yalin, S., Ergn, A., Erol, H., Yalcin, S
The group of researchers is now analyzing the data to see if those on GLP-1s who developed cancer have a significant difference in cancer outcomes compared with those with cancer but not taking a GLP-1
Striking the balance: GLP-1/Glucagon Co-agonism as a treatment strategy for obesity